JBC Biosymposia, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M602551200 on September 15, 2006

J. Biol. Chem., Vol. 281, Issue 45, 34124-34134, November 10, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/45/34124    most recent
M602551200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Azad, N.
Right arrow Articles by Rojanasakul, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Azad, N.
Right arrow Articles by Rojanasakul, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

S-Nitrosylation of Bcl-2 Inhibits Its Ubiquitin-Proteasomal Degradation

A NOVEL ANTIAPOPTOTIC MECHANISM THAT SUPPRESSES APOPTOSIS*

Neelam Azad{ddagger}, Val Vallyathan§, Liying Wang§, Vimon Tantishaiyakul, Christian Stehlik||, Stephen S. Leonard§, and Yon Rojanasakul{ddagger}1

From the {ddagger}Department of Pharmaceutical Sciences and ||Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, West Virginia 26506, the §Pathology and Physiology Research Branch, National Institute for Occupational, Safety and Health, Morgantown, West Virginia 26505, and the Department of Pharmaceutical Chemistry, Songkla University, Songkla 90110, Thailand

Bcl-2 is a key apoptosis regulatory protein of the mitochondrial death pathway whose function is dependent on its expression levels. Although Bcl-2 expression is controlled by various mechanisms, post-translational modifications, such as ubiquitination and proteasomal degradation, have emerged as important regulators of Bcl-2 function. However, the underlying mechanisms of this regulation are unclear. We report here that Bcl-2 undergoes S-nitrosylation by endogenous nitric oxide (NO) in response to multiple apoptotic mediators and that this modification inhibits ubiquitin-proteasomal degradation of Bcl-2. Inhibition of NO production by the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide and by NO synthase inhibitor aminoguanidine effectively inhibited S-nitrosylation of Bcl-2, increased its ubiquitination, and promoted apoptotic cell death induced by chromium (VI). In contrast, the NO donors dipropylenetriamine NONOate and sodium nitroprusside showed opposite effects. The effect of NO on Bcl-2 stability was shown to be independent of its dephosphorylation. Mutational analysis of Bcl-2 further showed that the two cysteine residues of Bcl-2 (Cys158 and Cys229) are important in the S-nitrosylation process and that mutations of these cysteines completely inhibited Bcl-2 S-nitrosylation. Treatment of the cells with other stress inducers, including Fas ligand and buthionine sulfoxide, also induced Bcl-2 S-nitrosylation, suggesting that this is a general phenomenon that regulates Bcl-2 stability and function under various stress conditions. These findings indicate a novel function of NO and its regulation of Bcl-2, which provides a key mechanism for the control of apoptotic cell death and cancer development.


Received for publication, March 17, 2006 , and in revised form, September 14, 2006.

* This work was supported by National Institutes of Health Grant HL076340. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Dept. of Pharmaceutical Sciences, West Virginia University, P.O. Box 9530, Morgantown, WV 26506. E-mail: yrojanasakul{at}hsc.wvu.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
N. Azad, A. K. V. Iyer, A. Manosroi, L. Wang, and Y. Rojanasakul
Superoxide-mediated proteasomal degradation of Bcl-2 determines cell susceptibility to Cr(VI)-induced apoptosis
Carcinogenesis, August 1, 2008; 29(8): 1538 - 1545.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. N. Jorgensen, A. McKee, M. Wang, E. Kushnir, J. White, Y. Refaeli, J. W. Kappler, and P. Marrack
Bim and Bcl-2 Mutually Affect the Expression of the Other in T Cells
J. Immunol., September 15, 2007; 179(6): 3417 - 3424.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.